Salivary gland neoplasm: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
ICDO = | | ICDO = | | ||
OMIM = | | OMIM = | | ||
MedlinePlus = | MedlinePlus = | | ||
eMedicineSubj = | | eMedicineSubj = | | ||
eMedicineTopic = | | eMedicineTopic = | | ||
| Line 15: | Line 15: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 32: | Line 30: | ||
{{Tumors of lip, oral cavity and pharynx}} | {{Tumors of lip, oral cavity and pharynx}} | ||
[[Category:Oncology stub]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Revision as of 15:42, 22 January 2012
| Salivary gland neoplasm | |
| ICD-10 | C07-C08, D11 |
|---|---|
| ICD-9 | 142, 210.2 |
| MeSH | D012468 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tumors of the salivary glands (salivary gland neoplasm) may occur. These are usually benign, but may be malignant.
The most common type of benign tumor is pleomorphic adenoma, followed by Warthin's tumor.
The most common malignant tumor is mucoepidermoid carcinoma.
Eighty percent begin in the parotid gland.[1]